Radiation Oncology Market Scope And Analysis

Report Code : TIPRE00004195
Category : Life Sciences

Status : Published
No. of Pages : 170

Buy Now

Radiation Oncology Market Analysis 2021 to 2031

Buy Now

Radiation Oncology Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 8,924.44 Million
Market Size by 2031	US$ 23,620.56 Million
Global CAGR (2023 - 2031)	7.4%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Type External Beam Radiation Therapy Internal Beam Radiation Therapy By Application Breast Cancer Prostate Cancer Lung Cancer Head & Neck Cancer Cervical Cancer
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Varian Medical Systems Inc Elekta AB Accuracy Incorporated IBA Worldwide Ion Beam Applications SA Becton Dickinson Co Perspective Therapeutics Inc Nordion Mevion Medical Systems NTP Radioisotopes Mallinckrodt Plc

Radiation Oncology Market News and Recent Developments

The radiation oncology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

Curium has submitted a new drug application (NDA) for its lutetium-177 (Lu-177) DOTATATE radiopharmaceutical for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETS). The radiopharmaceutical is designed to be injected into patients to deliver Lu-177 radiation directly to tumors. (Curium, Company Website, July 2024)
IBA has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare, and Proton International, for the installation of a Proteus ONE compact proton therapy system. (IBA, Company Website, May 2024)
Varian has received 510(k) clearance from the US Food and Drug Administration (FDA) and the CE mark in the European Union for Halcyon and Ethos radiotherapy systems featuring Varian's HyperSight imaging solution. HyperSight enables clinicians to capture high-quality images of patients during their daily radiation treatments. (Varian, Company Website, February 2024)

Radiation Oncology Market Report Coverage and Deliverables

The "Radiation Oncology Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Radiation oncology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Radiation oncology market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter's Five Forces and SWOT analysis
Radiation oncology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the radiation oncology market
Detailed company profiles